CYMABAY THERAPEUTICS INC OM
(NASDAQ:CBAY)
Last update: 7:00PM
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

CYMABAY THERAPEUTICS INC OM Stock (NASDAQ:CBAY), Quotes and News Summary

CYMABAY THERAPEUTICS INC OM Stock (NASDAQ: CBAY) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / -
Day Range- - -
52 Wk Range- - -
Market Cap-
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest-
Days to Cover1.57

Recent News

Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment Production
Gilead Sciences plans to quadruple cell therapy cancer treatment production by 2026. With a focus on CAR-T treatments like Yescarta and Tecartus, Gilead aims to diversify into oncology. Anticipating a third of revenue from oncology by decade's end.
Vandana Singh
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
As of March 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Avi Kapoor
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potential in seladelpar's impact on PBC and pruritus, projecting peak sales of $800 million.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
11
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.6
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CBAY

FAQ

Q

How do I buy CYMABAY THERAPEUTICS INC OM (CBAY) stock?

A

You can purchase shares of CYMABAY THERAPEUTICS INC OM (NASDAQ: CBAY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CYMABAY THERAPEUTICS INC OM's (CBAY) competitors?

A

There are no as such competitors for CYMABAY THERAPEUTICS INC OM.

Q

What is the target price for CYMABAY THERAPEUTICS INC OM (CBAY) stock?

A

The latest price target for CYMABAY THERAPEUTICS INC OM (NASDAQ: CBAY) was reported by HC Wainwright & Co. on Thursday, February 29, 2024. The analyst firm set a price target for 32.50 expecting CBAY to fall to within 12 months (a possible NaN% downside). 34 analyst firms have reported ratings in the last year.

Q

Current Stock Price for CYMABAY THERAPEUTICS INC OM (CBAY)?

A

The stock price for CYMABAY THERAPEUTICS INC OM (NASDAQ: CBAY) is $ last updated December 31, 1969 at 7:00 PM EST.

Q

Does CYMABAY THERAPEUTICS INC OM (CBAY) pay a dividend?

A

There are no upcoming dividends for CYMABAY THERAPEUTICS INC OM.

Q

When is CYMABAY THERAPEUTICS INC OM (NASDAQ:CBAY) reporting earnings?

A

CYMABAY THERAPEUTICS INC OM’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Q

Is CYMABAY THERAPEUTICS INC OM (CBAY) going to split?

A

There is no upcoming split for CYMABAY THERAPEUTICS INC OM.

Q

What sector and industry does CYMABAY THERAPEUTICS INC OM (CBAY) operate in?

A

CYMABAY THERAPEUTICS INC OM is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.